US2015224154A1PendingUtilityA1

Low/High Dose Probiotic Supplements And Methods Of Their Use

Assignee: NUTRITION PHYSIOLOGY COMPANY LLCPriority: Apr 20, 2010Filed: Apr 16, 2015Published: Aug 13, 2015
Est. expiryApr 20, 2030(~3.7 yrs left)· nominal 20-yr term from priority
A61P 31/04A61P 31/00A61K 2035/115A61K 38/47A61K 35/74A61K 35/747A61K 2300/00Y02A50/30
41
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Methods and compositions are hereby disclosed for reducing the numbers of E. coli O157:H7, Salmonella or other pathogens in an animal. The methods include administering to the animal a lactic acid producing bacterium at a relatively low dosage in combination with a lactate utilizing bacterium, followed by administration of the lactic acid producing bacterium at a relatively high dosage. The disclosed methods help achieve pre-harvest food safety and enhance feed performance while keeping the total cost relatively low. The preferred lactic acid producing bacterium is Lactobacillus acidophilus/animalis and the preferred lactate utilizing bacterium is Propionibacterium freudenreichii.

Claims

exact text as granted — not AI-modified
We claim: 
     
         1 . A method for reducing the numbers of pathogens in an animal, said method comprising:
 (a) administering to said animal at least one lactic acid producing bacterium and at least one lactate utilizing bacterium for at least 30 days, wherein said lactic acid producing bacterium is administered to said animal at a dosage of between 1×10 5  and 5×10 7  CFU per day, and said lactate utilizing bacterium is administered to said animal at a dosage of between 5×10 8  and 5×10 9  CFU per day; and   (b) administering to said animal at least one lactic acid producing bacterium and at least one lactate utilizing bacterium for at least 20 days, wherein said lactic acid producing bacterium is administered to said animal at a dosage of between 5×10 8  and 5×10 9  CFU per day, and said lactate utilizing bacterium is administered to said animal at a dosage of between 5×10 8  and 5×10 9  CFU per day,   wherein step (a) precedes step (b).   
     
     
         2 . The method of  claim 1 , wherein said at least one lactic acid producing bacterium is a  Lactobacillus acidophilus/animalis  strain selected from the group consisting of C28, M35, LA45, LA51 and L411 strains. 
     
     
         3 . The method of  claim 2 , wherein the  Lactobacillus acidophilus/animalis  strain is the LA51 strain. 
     
     
         4 . The method of  claim 1 , wherein said at least one lactate utilizing bacterium is a  Propionibacterium freudenreichii  strain selected from the group consisting of P9, PF24, P42, P93 and P99 strains. 
     
     
         5 . The method of  claim 1 , wherein step (b) is performed for 20-60 days. 
     
     
         6 . The method of  claim 1 , wherein the administration of said at least one lactic acid producing bacterium and said at least one lactate utilizing bacterium in step (a) or step (b) is performed continuously on a daily basis. 
     
     
         7 . The method of  claim 1 , wherein the pathogen is selected from the group consisting of  Escherichia coli, Salmonella  spp., and  Staphylococcus aureus.   
     
     
         8 . The method of  claim 1 , wherein said lactic acid producing bacterium is administered in step (a) to said animal at a dosage of between 8×10 6  and 2×10 7  CFU per day. 
     
     
         9 . The method of  claim 1 , wherein said lactic acid producing bacterium is administered in step (a) to said animal at a dosage of about 1×10 7  CFU per day. 
     
     
         10 . The method of  claim 1 , wherein said lactic acid producing bacterium is administered in step (b) to said animal at a dosage of between 8×10 8  and 2×10 9  CFU per day. 
     
     
         11 . The method of  claim 1 , wherein said lactic acid producing bacterium is administered in step (b) to said animal at a dosage of about 1×10 9  CFU per day. 
     
     
         12 . The method of  claim 1 , wherein said lactate utilizing bacterium is administered in steps (a) and (b) to said animal at a dosage of between 8×10 8  and 2×10 9  CFU per day. 
     
     
         13 . The method of  claim 1 , wherein said lactate utilizing bacterium is administered in steps (a) and (b) to said animal at a dosage of about 1×10 9  CFU per day. 
     
     
         14 . The method of  claim 1 , wherein the administration in step (a) or step (b) is performed discontinuously. 
     
     
         15 . A method for reducing the numbers of pathogens in an animal said method comprising:
 (a) administering to said animal at least one lactic acid producing bacterium for at least 30 days, wherein said lactic acid producing bacterium is administered to said animal at a dosage of between 1×10 5  and 5×10 7  CFU per day; and   (b) administering to said animal at least one lactic acid producing bacterium for at least 20 days, wherein said lactic acid producing bacterium is administered to said animal at a dosage of between 5×10 8  and 5×10 9  CFU per day,   wherein step (a) precedes step (b).   
     
     
         16 . The method of  claim 15 , wherein said at least one lactic acid producing bacterium is a  Lactobacillus acidophilus/animalis  strain selected from the group consisting of C28, M35, LA45, LA51 and L411 strains. 
     
     
         17 . The method of  claim 15 , wherein step (b) is performed for 20-60 days. 
     
     
         18 . The method of  claim 15 , wherein the administration of said at least one lactic acid producing bacterium in step (a) or (b) is performed continuously on a daily basis. 
     
     
         19 . The method of  claim 15 , wherein said lactic acid producing bacterium is administered in step (a) to said animal at a dosage of between 8×10 6  and 2×10 7  CFU per day. 
     
     
         20 . The method of  claim 15 , wherein said lactic acid producing bacterium is administered in step (b) to said animal at a dosage of between 8×10 8  and 2×10 9  CFU per day. 
     
     
         21 . A method for reducing the numbers of pathogens in an animal, said method comprising:
 (a) administering to said animal at least one lactic acid producing bacterium and at least one lactate utilizing bacterium for at least 30 days, wherein said lactic acid producing bacterium is administered to said animal at a dosage of between 1×10 6  and 5×10 7  CFU per day, and said lactate utilizing bacterium is administered to said animal at a dosage of between 5×10 8  and 5×10 9  CFU per day; and   (b) administering to said animal at least one lactic acid producing bacterium and at least one lactate utilizing bacterium for at least 20 days, wherein said lactic acid producing bacterium is administered to said animal at a dosage of between 5×10 8  and 5×10 9  CFU per day, and said lactate utilizing bacterium is administered to said animal at a dosage of between 5×10 8  and 5×10 9  CFU per day,   wherein step (a) precedes step (b), and said at least one lactic acid producing bacterium is a  Lactobacillus acidophilus/animalis  strain selected from the group consisting of C28, M35, LA45, LA51 and L411 strains, and said at least one lactate utilizing bacterium is a  Propionibacterium freudenreichii  strain selected from the group consisting of P9, PF24, P42, P93 and P99 strains.

Join the waitlist — get patent alerts

Track US2015224154A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.